The prevalence of autoantibodies in complex regional pain syndrome type i

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Dirckx, Maaike ^a   Schreurs, Marco W J ^a   De Mos, Marissa ^a   Stronks, Dirk L ^a   Huygen, Frank J P M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTINEURONAL ANTIBODY; ANTINUCLEAR ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODY;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; COMPARATIVE STUDY; COMPLEX REGIONAL PAIN SYNDROME TYPE I; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NEUROFILAMENT; NORMAL VALUE; PATHOGENESIS; PATHOPHYSIOLOGY; POPULATION; PREVALENCE; PRIORITY JOURNAL; BLOOD; COMPLEX REGIONAL PAIN SYNDROME; IMMUNOLOGY; MIDDLE AGED; PHYSIOLOGY;

AUTOANTIBODIES; AUTOIMMUNITY; COMPLEX REGIONAL PAIN SYNDROMES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE;

EID: 84924204327     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/718201     Document Type: Article

References (34)

1. M. de Mos, M. C. J. M. Sturkenboom, and F. J. P. M. Huygen, "Current understandings on complex regional pain syndrome," Pain Practice, vol. 9, no. 2, pp. 86-99, 2009.
2. P. H. J. M. Veldman, H. M. Reynen, I. E. Arntz, and R. J. A. Goris, "Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients," The Lancet, vol. 342, no. 8878, pp. 1012-1016, 1993.
3. F. J. P. M. Huygen, A. G. J. de Bruijn, M. T. de Bruin, J. G. Groeneweg, J. Klein, and F. J. Zijlstra, "Evidence for local inflammation in complex regional pain syndrome type 1," Mediators of Inflammation, vol. 11, no. 1, pp. 47-51, 2002.
4. F. Wesseldijk, F. J. Huygen, C. Heijmans-Antonissen, S. P. Niehof, and F. J. Zijlstra, "Tumor necrosis factor-α and interleukin-6 are not correlated with the characteristics of Complex Regional Pain Syndrome type 1 in 66 patients," European Journal of Pain, vol. 12, no. 6, pp. 716-721, 2008.
5. M. Dirckx, D. L. Stronks, G. Groeneweg, and F. J. P. M. Huygen, "Effect of immunomodulating medications in complex regional pain syndrome: a systematic review," Clinical Journal of Pain, vol. 28, no. 4, pp. 355-363, 2012.
6. M. de Mos, A. G. J. de Bruijn, F. J. P.M. Huygen, J. P. Dieleman, B. H. C. Stricker, and M. C. J. M. Sturkenboom, "The incidence of complex regional pain syndrome: a population-based study," Pain, vol. 129, no. 1-2, pp. 12-20, 2007.
7. A. Mailis and J. Wade, "Profile of Caucasian women with possible genetic predisposition to reflex sympathetic dystrophy: a pilot study," The Clinical Journal of Pain, vol. 10, no. 3, pp. 210-217, 1994.
8. M. A. Kemler, A. C. van de Vusse, E. M. van den Berg-Loonen, G. A. M. Barendse, M. van Kleef, and W. E. J. Weber, "HLADQ1 associated with reflex sympathetic dystrophy," Neurology, vol. 53, no. 6, pp. 1350-1351, 1999.
9. A. M. de Rooij, M. Florencia Gosso, G. W. Haasnoot et al., "HLA-B62 and HLA-DQ8 are associated with complex regional pain syndrome with fixed dystonia," Pain, vol. 145, no. 1-2, pp. 82-85, 2009.
10. M. de Mos, F. J. P. M. Huygen, J. P. Dieleman, J. S. H. A. Koopman, B. H. C. Stricker, and M. C. J. M. Sturkenboom, "Medical history and the onset of complex regional pain syndrome (CRPS)," Pain, vol. 139, no. 2, pp. 458-466, 2008.
11. R. J. Schwartzman, C. Gurusinghe, and E. Gracely, "Prevalence of complex regional pain syndrome in a cohort of multiple sclerosis patients," Pain Physician, vol. 11, no. 2, pp. 133-136, 2008.
12. A. Goebel, H. Vogel, O. Caneris et al., "Immune responses to campylobacter and serum autoantibodies in patients with complex regional pain syndrome," Journal of Neuroimmunology, vol. 162, no. 1-2, pp. 184-189, 2005.
13. A. C. van de Vusse, V. J. Goossens, M. A. Kemler, and W. E. J. Weber, "Screening of patients with complex regional pain syndrome for antecedent infections," The Clinical Journal of Pain, vol. 17, no. 2, pp. 110-114, 2001.
14. O. Gross, M. Tschernatsch, M. E. Bräu et al., "Increased seroprevalence of parvovirus B 19 IgG in complex regional pain syndrome is not associatedwith antiendothelial autoimmunity," European Journal of Pain, vol. 11, no. 2, pp. 237-240, 2007.
15. F. Blaes, K. Schmitz, M. Tschernatsch et al., "Autoimmune etiology of complex regional pain syndrome (M. Sudeck)," Neurology, vol. 63, no. 9, pp. 1734-1736, 2004.
16. D. Kohr, M. Tschernatsch, K. Schmitz et al., "Autoantibodies in complex regional pain syndrome bind to a differentiation-dependent neuronal surface autoantigen," Pain, vol. 143, no. 3, pp. 246-251, 2009.
17. A. Goebel, M. I. Leite, L. Yang et al., "The passive transfer of immunoglobulin G serum antibodies from patients with longstanding complex regional pain syndrome," European Journal of Pain, vol. 15, no. 5, pp. 504.e1-504.e6, 2011.
18. A. Goebel, A. Baranowski, K. Maurer, A. Ghiai, C. McCabe, and G. Ambler, "Intravenous immunoglobulin treatment of the complex regional pain syndrome: a randomized trial," Annals of Internal Medicine, vol. 152, no. 3, pp. 152-158, 2010.
19. A. Goebel and F. Blaes, "Complex regional pain syndrome, prototype of a novel kind of autoimmune disease," Autoimmunity Reviews, vol. 12, no. 6, pp. 682-686, 2013.
20. R. J. T. Smeenk, "Antinuclear antibodies: cause of disease or caused by disease?" Rheumatology, vol. 39, no. 6, pp. 581-584, 2000.
21. H. Hooijkaas, R. Smeenk, and F. Gmelig Meyling, "Systemic autoimmune diseases: appropriate serological diagnostics," Nederlands Tijdschrift voor Klinische Chemie en Laboratoriumgeneeskunde, vol. 31, no. 4, pp. 257-268, 2006.
22. E. Lancaster and J. Dalmau, "Neuronal autoantigens-pathogenesis, associated disorders and antibody testing," Nature Reviews Neurology, vol. 8, no. 7, pp. 380-390, 2012.
23. S. Bruehl, R.N. Harden, B. S. Galer et al., "External validation of IASP diagnostic criteria for Complex Regional Pain Syndrome and proposed research diagnostic criteria," Pain, vol. 81, no. 1-2, pp. 147-154, 1999.
24. N. Agmon-Levin, J. Damoiseaux, C. Kallenberg et al., "International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies," Annals of the Rheumatic Diseases, vol. 73, no. 1, pp. 17-23, 2014.
25. J. W. B. Moll, J. C. Antoine, H. R. Brashear et al., "Guidelines on the detection of paraneoplastic anti-neuronal-specific antibodies: report from the workshop to the fourth meeting of the international society of neuro-immunology on paraneoplastic neurological disease, held October 22-23, 1994, in Rotterdam, the Netherlands," Neurology, vol. 45, no. 10, pp. 1937-1941, 1995.
26. D. S. Pisetsky, "Antinuclear antibodies in healthy people: the tip of autoimmunity's iceberg?" Arthritis Research and Therapy, vol. 13, no. 2, article 109, 2011.
27. A. S. Wiik, M. Høier-Madsen, J. Forslid, P. Charles, and J. Meyrowitsch, "Antinuclear antibodies: a contemporary nomenclature using HEp-2 cells," Journal of Autoimmunity, vol. 35, no. 3, pp. 276-290, 2010.
28. A. R. Karim, R. G. Hughes, J. B. Winer, A. C. Williams, and A. R. Bradwell, "Paraneoplastic neurological antibodies: a laboratory experience," Annals of the New York Academy of Sciences, vol. 1050, pp. 274-285, 2005.
29. A. Tsutsumi, T. Horita, J. Ohmuro et al., "Reflex sympathetic dystrophy in a patient with the antiphospholipid syndrome," Lupus, vol. 8, no. 6, pp. 471-473, 1999.
30. B. E. Ostrov, A. H. Eichenfield, D. P. Goldsmith, and H. R. Schumacher, "Recurrent reflex sympathetic dystrophy as a manifestation of systemic lupus erythematosus," The Journal of Rheumatology, vol. 20, no. 10, pp. 1774-1776, 1993.
31. A. L. Oaklander and H. L. Fields, "Is reflex sympathetic dystrophy/complex regional pain syndrome type I a small-fiber neuropathy?" Annals of Neurology, vol. 65, no. 6, pp. 629-638, 2009.
32. Y. Zhang and P. Popovich, "Roles of autoantibodies in central nervous system injury," Discovery medicine, vol. 11, no. 60, pp. 395-402, 2011.
33. C. Sommer, "Anti-autonomic nervous system antibodies in CRPS," Pain, vol. 152, no. 12, pp. 2675-2676, 2011.
34. A. Goebel, M. Stock, R. Deacon, G. Sprotte, and A. Vincent, "Intravenous immunoglobulin response and evidence for pathogenic antibodies in a case of complex regional pain syndrome 1," Annals of Neurology, vol. 57, no. 3, pp. 463-464, 2005.